Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Absci
What AI says about Absci
Absci is a generative AI drug creation company dedicated to unlocking novel biology and creating better biologics for patients faster. Their Integrated Drug Creation Platform combines advanced AI models with high-throughput wet lab capabilities to accelerate the drug discovery process.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Products & Services
Integrated Drug Creation Platform
A platform that combines AI-driven drug design with wet lab validation to create biologics efficiently.
AI Target Discovery
An AI-enabled service for novel target discovery using reverse immunology to identify antibodies.
Common Questions
What is Absci's mission?
Absci's mission is to create better biologics for patients, faster, by leveraging generative AI in drug discovery.
How does Absci's Integrated Drug Creation Platform work?
The platform utilizes a cycle of data generation, AI model training, and wet lab validation to design and optimize biologics in as little as six weeks.
What types of diseases does Absci target?
Absci focuses on developing biologics against challenging diseases that are difficult to drug using conventional methods.
Where are Absci's facilities located?
Absci has state-of-the-art wet lab facilities in Vancouver, WA, an AI Research Lab in NYC, and a Drug Innovation Center in Zug, Switzerland.
What is the significance of reverse immunology in Absci's approach?
Reverse immunology allows Absci to identify antibodies produced by super immune responders, facilitating the discovery of novel targets for drug development.